Global pharma major Lupin Limited (Lupin) announced the launch of United Food and Drug Administration (FDA) approved bumetanide injection USP, 1 mg/4 mL (0.25 mg/mL) single-dose vials and 2.5 mg/10 mL ...
9hon MSN
October saw subdued growth in the Indian pharmaceutical market (IPM), with growth remaining in the low single digits, mainly ...
The Nifty Pharma index closed on a note on Monday. Shares of Ipca Laboratories Ltd.(up 1.97 per cent), Lupin Ltd.(up 0.99 per ...
Nifty moved in a tight range of 82 points, and ended slightly below the psychologically crucial level of 15,700. NEW DELHI: ...
The 17th edition of the CPHI and PMEC expo showcasing the pharmaceutical industry's modernisation, innovation and ...
The 17th CPHI & PMEC India Expo, held Nov 26-28 in Greater Noida, showcases pharma innovation, sustainability, and ...
The 17th CPHI & PMEC India Expo will showcase the latest advancements in pharmaceutical modernization, innovation, and ...
JB Pharma, Sun, Torrent ,Lupin, Abbott, Glenmark, Dr Reddy’s Cipla, Zydus remained among Key pharma market growth drivers in ...
An analyst from YES Securities said that Lupin has broken down from a descending triangle pattern on daily timeframe, ...
Mankind Pharma Ltd. and Lupin Ltd. each posted 4.1% growth, trailing the market benchmark. Zydus Lifesciences Ltd. and Dr.
Chinese pharma giant Shanghai Pharmaceuticals is in talks with major Indian pharmaceutical companies for greater access to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback